Neuronetics, Inc. (STIM): Revenue
$149.16M
Year ended 2025-12-31
$155.10M
Trailing 12 months to 2026-06-30
+31.8%
3-year compound annual growth
+24.8%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $149.16M | +99.2% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $74.89M | +5.0% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $71.35M | +9.4% | 2026-03-17, From 2023-01-01 |
| 2022-12-31 | $65.21M | +17.9% | 2025-03-27, From 2022-01-01 |
| 2021-12-31 | $55.31M | +12.3% | 2024-03-08, From 2021-01-01 |
| 2020-12-31 | $49.24M | -21.4% | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | $62.66M | +18.7% | 2022-03-08, From 2019-01-01 |
| 2018-12-31 | $52.78M | +30.5% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $40.43M | +18.1% | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | $34.23M | n/a | 2019-03-05, From 2016-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | 2025-12-31 | $149.16M | +99.2% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $143.44M | +6.4% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $133.93M | +14.2% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $176.03M | +39.9% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $115.02M | -38.1% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $112.82M | -5.9% |
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $200.93M | +20.2% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $212.69M | +1.6% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $100.25M | +53.9% |
Compare STIM, INFU, XTNT, HTFL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗